Concepedia

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)

Manuel F. Ugarte‐Gil, Daniel Wojdyla, Guillermo Pons‐Estel, Luís J. Catoggio, Cristina Drenkard, Judith Sarano, Guillermo Berbotto, Eduardo Ferreira Borba, Emília Inoue Sato, João Carlos Tavares Brenol,

Annals of the Rheumatic Diseases · 2017 · 109 citations · 11 references

DOIFull text

Open access

References

11

Derivation of the sledai. A disease activity index for lupus patients

Claire Bombardier, Dafna D. Gladman, Murray B. Urowitz et al. · Arthritis & Rheumatism · 1992 · 4.5K citations

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

, , +6

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart et al. · Arthritis & Rheumatism · 2005 · 1.4K citations · Full text

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)

Kate Franklyn, Chak Sing Lau, Sandra Navarra et al. · Annals of the Rheumatic Diseases · 2015 · 683 citations

Prolonged remission in Caucasian patients with SLE: prevalence and outcomes

Margherita Zen, Luca Iaccarino, Mariele Gatto et al. · Annals of the Rheumatic Diseases · 2015 · 225 citations · Full text